Preliminary program
4th Nordic Platelet Symposium
Reykjavik 28. – 29. March 2025
Day 1: March 28, 2025
9:30 – 11:30
Immune Thrombocytopenia
(Chairs: Waleed Ghanima and John Semple)
- The Pathophysiology of ITP – what have we learned since the 3rd platelet symposium? (Sylvain Audia)
- The role of molecular biology in predicting response to treatment of ITP? (Tomas Jose Gonzales-Lopez)
- Real World Evidence exploring the potentials of existing agents (Henrik Frederiksen)
- ITP: New targets, new agents and new possibilities (Galina Tsykunova)
- The Potential Role of Artificial Intelligence in Advancing Immune Thrombocytopenia Research (Drew Provan and Waleed Ghanima)
11:30 – 11:45
Coffee Break
11:45 – 13:15
Platelet Clinical Lab
(Chair: Marie-Therese Ahlen)
- Assessment of platelet phenotypes by immunofluorescence microscopy on peripheral blood smears (Carlo Zaninetti)
- Platelet Function Studies (Timea Szanto)
- The APAC Antiplatelet-Anticoagulant Story (Riitta Lassilla)
13:15 – 14:00
Lunch Break
14:00 – 15:30
Whole Genome Sequencing in Platelet Disorders
(Chairs: Mimi Kjaersgaard and Eva Leinøe)
- WGS and inherited thrombocytopenia – new kids in the block (Eva Leinøe)
- An evidence-based framework to evaluate the Clinical Validity of Gene-Disease Associations (Andreas Ørslev Rasmussen)
- Outcome of WGS in ITP – pilot study (Eva Zetterberg)
15:30 – 15:45
Coffee Break
15:45 – 16:30
Nordic Platelet Symposium Keynote Lecture
Hemostasis without clot formation – how platelets guard the vasculature in inflammation, infection, and malignancy (Steffen Masberg)
16:30 – 17:15
Abstract Presentations
19:30
Dinner
Day 2: March 29, 2025
9:30 – 11:00
Platelets in Other Diseases
(Chairs: Riitta Lassila and John Semple)
- The association between BDNF, platelet dysfunction, and cognitive impairment (Marie Lordkipanidze)
- EV and serum markers and VTE population-based studies (Omri Snir)
- Platelet Factor 4 associated syndromes (Hanna Pitkänen)
11:00 – 11:15
Coffee Break
11:15 – 12:45
Platelets and Complement Disease
(Chair: Eva Zetterberg)
- The complement and contact systems in thrombotic kidney disease (Diana Karpman)
- The paradigm of complement inhibition in PNH (Alexandros Arvanitakis)
- Interactions between platelets and complement (Per Nilsson)
12:45 – 13:45
Lunch Break